News        Sectors        Watchlists

Fate Therapeutics, Inc. (FATE)

FATE stock forecast: buy or sell

Close on Sep 25th, 2020
$37.8 0.05%
3 months performance
Published: September 27th, 2020 - 20:18

FATE stock outlook

  • Fate Therapeutics closed on Friday at $37.80 (5.03%) prior to reporting financial results at
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide.

The opinions contained in this article are personal and should not be followed as recommendations for you to buy or sell shares. The author of this paper does not have any knowledge of the specific positions of the reader, his or her finances or what is in his or her best interest at any given time. All users should speak with their financial advisor before buying or selling any securities Opinions are expressed for education motives only

FATE stock charts

Should I buy Fate Therapeutics stock?

Even if you are a experienced or a novel trader, best trading results come from using an investing strategy that never leaves to random or subjective opinions when is the best moment to buy or sell stocks. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is FATE stock a buy?

Currently, Fate Therapeutics stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean FATE will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems

Should I sell Fate Therapeutics stock?

When you own a stock with some profit, it's really difficult to decide the good moment to sell and get your benefits. As when we have to buy shares, determining when is the best time to sell is not a whimsy decision, and we must follow our own trading strategy. Our trading system selects very simple strategies to guide us on when is a good time to sell a stock. Be aware that these strategies should not be used for shorting FATE stock

A golden rule is that you should never mantain a trading operation that produces greater losses than those expected at the time of purchase. The timing to sell your stock always has to be dictated by the stop-loss (automatic or manual)

Is it time to sell Fate Therapeutics stock?

Currently, Fate Therapeutics stock doesn't match any of our preferred sell setups, so if you hold Fate Therapeutics stock and your operation is in profit probably is not time to sell now

Analysts' recommendations to buy or sell Fate Therapeutics stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

We don't have any rating posted in the last month for Fate Therapeutics

Technical analysis

SMAs overview

A favorite tool of many trading systems are the moving averages, that easily show trend direction. A moving average is the average price of a stock over a set period of time. Moving averages are usually calculated on different periods depending on the trading timeframe 21, 50, 100 and 200 days are the most usual moving averages. You can found more about Moving Averages from sources like Wikipedia and Investopedia

FATE SMAs chart

Supports and resistances

Technical analysts use supports and resistances as a way to spot price points on a chart that may act as glass ceiling, preventing the price of a stock to move up or down. A support level is a level where the price may find support as it falls. This means that the price is more likely to "rebound" this level rather than break through it. Nevertheless, if the price breaks down the support, it is likely to continue falling until meeting another support level. In contrast, resistance levels are where the price tends to find opposition as it rises. Likewise, the price is more likely to "bounce off" at this level, and if it finally breaches this level, it will climb more easily until it finds the next resistance

The current resistances are:

  • R1: $38.52 (1.9% above)
  • R2: $39.45 (4.37% above)
  • The current support levels are:

  • S1: $37.35 (-1.19% below)
  • S2: $37.24 (-1.48% below)
  • S3: $32.39 (-14.31% below)
  • Bollinger bands

    So-called Bollinger bands are a widely known practice introduced by John Bollinger. By essence, the Bollinger Bands are lines that fluctuate around a centralmoving average, ranging the distance from the bottom to the top depending on market volatility. They are usually plotted by an offset of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20

    Since the price surpassed the upper band on September 18, the price has corrected downwards by 4.18%

    FATE RSI chart

    Relative strength index

    The Relative Strength Index is an oscillator-type indicator that measures price movements to spot when the share or financial asset is overbought or oversold. Oscillator indicators, such as relative strength, are intended to indicate values in the range of 0-100. The relative strength indicator is one of the best known and most widely used indicators, invented by J. Welles Wilder in the late 1970s

    When the RSI fluctuates for so long below 70 and above 30, without any indication of overvaluation and undervaluation, the indicator is of little use, and we currently are in one of these cases.

    FATE RSI chart

    Earnings and financials

    Second-quarter shareholders call was hosted by FATE in early August after posting the earnings report. FATE posted second-quarter earnings of $-0.35 per share on revenue of $5.5 million. The market estimate was $-0.27 per share on revenue of $14.0 million.

    By comparison, the EPS for the same quarter last year was $-0.36, so reported EPS is a gain of 2.78%. Looking at turnover, figures skyrocketed a 94% compared to $2.8M year over year.

    FATE is presenting earnings report. Earnings reporting day has a more than usual risk for stock traders as the results disclosed can gap up or down the stock price with lower volume and not honouring your buy/stop-loss orders. Have a look company's website to confirm time and details on the earnings call and the earnings report.

    FATE revenues and profits chart